It is with great sadness that IDDO has learnt of the passing of Professor Mamadou Pathé Diallo, a valued member of the IDDO team since 2019. Professor Diallo had been a Professor of Paediatrics since 1988 and was the Head of the Medical Centre & Health Counselling (CEMECO) in Kipé, the Paediatric, H...

It was great to welcome researchers Dr Vijayakumar Balakrishnan (ICMR-VCRC), Dr Hemant Mahajan (ICMR-RMRIMS) to IDDO to update on their work across malaria, visceral leishmaniasis, and filariasis. IDDO is building a partnership with the Indian Council of Medical Research (ICMR) to exchange and sh...

IDDO’s Medicine Quality Research Group delivered in-person training to researchers in Mozambique and Ghana to support a study into the quality of three antibiotics.

Come and meet us at this year’s ASTMH 71st Annual Meeting - the first fully in-person meeting since 2019. Thousands of delegates are expected to attend with leading global health researchers from more than 111 countries around the world. During the conference we have several posters, talks, meetings...

Join IDDO and WWARN Director, Professor Philippe Guérin at this year's RSTMH Annual Meeting where he will be discussing topical issues in malaria and in resistance with a wide range of speakers and panellists.

In the first published study of its kind, a new WWARN paper in the Malaria Journal has created near-real-time maps to support antimalarial drug resistance monitoring, using routine malaria surveillance data and individually patient linked data on molecular markers of antimalarial drug resistance.

A new WWARN study, published in BMC Medicine, provided evidence for a World Health Organization (WHO) recommendation that a single primaquine target dose of 0.25 mg/kg is generally safe and well tolerated when given together with an ACT to treat malaria.

New studies suggest that substandard and falsified (SF) antimicrobials, in particular antibiotics, are widely spread with higher prevalence in low-and middle-income countries (LMIC). The quality of the evidence available in the scientific literature is poor but the issue has significant risks for On...

Researchers have created a mathematical model to predict genetic resistance to antimalarial drugs in Africa to manage one of the biggest threats to global malarial control.

The Medicine Quality Research Group organised a multidisciplinary hybrid meeting at Keble College, Oxford, July 3 to 6, for the FORESFA project ‘Forensic epidemiology and impact of substandard and falsified antimicrobials on public health’, funded by a Wellcome Collaborative Award.

Patients affected by COVID-19 should be treated according to the severity of their disease. However, new research out today finds that not all key national or international organisations define severity in the same way.

Taking place in Cartagena, Colombia, the WordLeish7 Conference reunites the visceral leishmaniasis (VL) scientific and research community in-person for the first time in four-years.

Microscopic examination of Giemsa-stained blood films is key to quantifying and detecting malaria parasites but there can be difficulties in ensuring both a high-quality manual reading and inter-reader reliability. The EasyScan GO was developed as a potential solution to this, a microscopy device us...

Find out more about what we’ve been up to in our latest newsletter. There are updates on our COVID-19 research, including our collaboration with ISARIC, which has assembled the world’s largest global database on COVID-19 clinical data.

Drug-resistant malaria is now a critical public health emergency on a global scale. In a new editorial a diverse group of malaria researchers, including WWARN senior scientists, have highlighted that the artemisinin confirmed recently in Rwanda and Uganda is likely just the 'tip of the spear', with ...

Hear from our Director, Professor Philippe Guérin, at the Geneva Health Forum’s plenary roundtable on 4 May on “Data sharing in the time of COVID-19: What works and what we need”.

The Indian government’s Union Cabinet, chaired by Prime Minister Shri Narendra Modi, has approved a Memorandum of Understanding (MoU) between the Indian Council of Medical Research (ICMR) and the Infectious Diseases Data Observatory (IDDO), based at the University of Oxford.

WWARN researchers have been assessing the recommended minimum follow-up period in capturing polymerase chain reaction (PCR)-confirmed recrudescence following treatment with fixed-dose artemisinin combination therapies (ACTs) for patients with uncomplicated Plasmodium falciparum malaria.

A key expert invited to speak at WHO’s recent Health Data Governance Summit was Cherif Mahamoud Sama, a recipient of TDR’s Clinical Research and Development Fellowship (CRDF).

Last year, the Indian Council for Medical Research (ICMR) National Institute of Malaria Research (NIMR) and IDDO began collaborating on a joint capacity building venture to train young researchers across three infectious diseases.